EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

5‐Aza‐2′‐deoxycytidine‐mediated DNA hypomethylation with and without concurrent insulin resistance suppresses myotube mitochondrial capacity

Caroline N Rivera, Madison M Kamer, Norah E Cook, Macey R McGovern, Rachel M Watne, Andrew J Wommack, Roger A Vaughan

Cell Biochemistry and Function · 2023

DOI: 10.1002/cbf.3878 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Biochemistry and Function, 2023. Verfasst von Caroline N Rivera und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health and Human Performance, High Point University, High Point, North Carolina, USA. Hauptthemen laut MEDLINE: Insulin Resistance, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Department of Health and Human Performance within the Congdon School of Health Sciences, Summer Undergraduate Research Fellowship (SURF) within the Congdon School of Health Sciences, HPU Natural Science Fellows Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type 2 diabetes is characterized by elevated blood glucose and reduced insulin sensitivity in target tissues. Moreover, reduced mitochondrial metabolism and expressional profile of genes governing mitochondrial metabolism (such as peroxisome proliferator‐activated receptor gamma coactivator 1‐alpha [PGC‐1α]) are also reduced during insulin resistance. Epigenetic regulation via DNA methylation of genes including PGC‐1α may contribute to diminished mitochondrial capacity, while hypomethylation of PGC‐1α (such as that invoked by exercise) has been associated with increased PGC‐1α expression and favorable metabolic outcomes. The purpose of the present report is to characterize the effects of DNA hypomethylation on myotube metabolism and expression of several related metabolic targets. C2C12 myotubes were treated with 5‐Aza‐2′‐deoxycytidine (5‐Aza) for either 24 or 72 h both with and without hyperinsulinemic‐induced insulin resistance. Mitochondrial and glycolytic metabolism were measured via oxygen consumption and extracellular acidification rate, respectively. Metabolic gene and protein expression were assessed via quantitative real time polymerase chain reaction and western blot analysis, respectively. Though expression of PGC‐1α and other related targets remained unaltered, insulin resistance and 5‐Aza treatment significantly reduced mitochondrial metabolism. Similarly, peak glycolytic metabolism was diminished by 5‐Aza‐treated cells, while basal glycolytic metabolism was unaltered. 5‐Aza also reduced the expression of branched‐chain amino acid (BCAA) catabolic components, however BCAA utilization was enhanced during insulin resistance with 5‐Aza treatment. Together the present work provides proof‐of‐concept evidence of the potential role of DNA methylation in the regulation of mitochondrial metabolism and the potential interactions with insulin resistance in a model of skeletal muscle.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin ResistanceDiabetes Mellitus, Type 2HumansDecitabineDNA MethylationEpigenesis, GeneticMuscle Fibers, SkeletalMuscle, SkeletalInsulinAmino Acids, Branched-ChainDNAPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha

Stichwörter der Autor:innen

epigeneticsinsulin resistancemitochondrial biogenesisskeletal muscle

Substanzen

DecitabineInsulinAmino Acids, Branched-ChainDNAPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha

Autor:innen und Institutionen

  • Department of Health and Human Performance, High Point University, High Point, North Carolina, USA.
  • Department of Chemistry, High Point University, High Point, North Carolina, USA.

Förderung

  • Department of Health and Human Performance within the Congdon School of Health Sciences
  • Summer Undergraduate Research Fellowship (SURF) within the Congdon School of Health Sciences
  • HPU Natural Science Fellows Program
  • Shimadzu Partnership for Academics, Research and Quality of Life (SPARQ) Program

Zitieren

APA

Rivera, C. N., Kamer, M. M., Cook, N. E., McGovern, M. R., Watne, R. M., Wommack, A. J., & Vaughan, R. A. (2023). 5‐Aza‐2′‐deoxycytidine‐mediated DNA hypomethylation with and without concurrent insulin resistance suppresses myotube mitochondrial capacity. Cell Biochemistry and Function. https://doi.org/10.1002/cbf.3878

Vancouver

Rivera CN, Kamer MM, Cook NE, McGovern MR, Watne RM, Wommack AJ, et al. 5‐Aza‐2′‐deoxycytidine‐mediated DNA hypomethylation with and without concurrent insulin resistance suppresses myotube mitochondrial capacity. Cell Biochemistry and Function. 2023. doi:10.1002/cbf.3878

BibTeX
@article{Rivera2023,
  author = {Rivera, Caroline N and Kamer, Madison M and Cook, Norah E and McGovern, Macey R and Watne, Rachel M and Wommack, Andrew J and Vaughan, Roger A},
  title = {5‐Aza‐2′‐deoxycytidine‐mediated DNA hypomethylation with and without concurrent insulin resistance suppresses myotube mitochondrial capacity},
  journal = {Cell Biochemistry and Function},
  year = {2023},
  doi = {10.1002/cbf.3878}
}
Kostenlos starten →